以多元合作模式策略強化競爭優勢

Abstract

本研究以生技製藥產業為研究對象，探討其因應環境變化及產業複雜性的挑戰下，企業如何藉由不同合作模式的建立，強化本身的競爭優勢；藉由分析企業合作模式及管理機制，深入瞭解多元合作之間如何平衡，與公司既有資源的連結的關係，藉以了解合作對於強化競爭優勢的策略意涵。為蒐集個案所經歷的合作夥伴建立的資料，本研究以台灣前十大國資廠的個案公司，針對個案公司高層進行深入訪談，同時運用三角測定法以提高研究的可信度和結果的真實性。不同於過去研究以單一策略理論為基礎，蒐集資料時針對企業的不同合作之策略活動作多面向的探討，了解個案本身的動態學習的能力、核心優勢的發揮以及領導團隊的穩定性都將有助於企業實現更高效的合作成效。本研究中著重的多元合作模式分析出企業在無形資產（如技術專利、藥證）、事業版圖（市場及營運等）方面藉由合作建立了關鍵基礎，形成資源成功進入新市場。此多元合作的模式不僅提升了市場地位，更強化了整體產業競爭優勢。研究結果強調動態合作能力和競爭優勢與合作成效的正向關聯。在動態合作中，企業透過建立穩固的合作基礎和增強信任度，成功強化了產業競爭優勢。與合作夥伴的緊密連結，有助於建立穩定的合作基礎，提高信任度，進一步加強合作成效。總結來說，本研究有幾個發現，第一、動態調整能力是企業建立合作模式的重要關係，第二、多元合作若形成互補資源，將更有助於建立優勢，第三、企業漸進式的合作，促使企業在內部管理資源槓桿，進而強化合作資源帶來的優勢。本研究為本土中小型製藥企業或其他行業提供了實用的見解，有助於制定更有效合作策略的參考，強調了動態合作能力在企業競爭中的關鍵角色。This study focuses on the pharmaceutical industry to explore how companies cope with environmental changes and industry complexity, and how they strengthen their competitive advantage through establishing different cooperative patterns. By analyzing the ways of collaboration and management mechanisms, this research delves into how multiple cooperative balance with existing resources, aiming to understand the strategic implications of collaboration for enhancing competitive advantage. To collect data on the collaboration experiences of case companies, this study selects one of the top ten pharmaceutical companies in Taiwan as case studies and conducts in-depth interviews with senior executives. The triangulation method is employed to enhance the credibility of the research and the authenticity of the results. Unlike previous studies based on a single strategic theory, this research adopts a multifaceted approach to investigate various strategic activities of enterprises in collaboration, understanding how the dynamic learning ability, leveraging core competencies, and leadership stability of case companies contribute to more effective collaboration outcomes. The analysis of multiple cooperative patterns emphasizes that companies establish crucial foundations through collaboration in intangible assets (such as technological patents and drug licenses) and business territories (markets and operations), facilitating successful entry into new markets. This diversified collaboration not only enhances market position but also strengthens the overall industry's competitive advantage. The research results underscore a positive correlation between dynamic collaboration capability, competitive advantage, and collaboration effectiveness. Through dynamic collaboration, companies strengthen their industry's competitive advantage by building a solid collaborative foundation and enhancing trust. The close connection with partners helps establish a stable collaborative foundation, increase trust, and further strengthen collaboration effectiveness. In summary, several findings emerge from this study: first, dynamic adjustment capability is crucial for companies to establish collaborative relationships; second, multiple cooperation, if complementary in resources, contributes to establishing advantages; third, the incremental collaboration of enterprises prompts them to gain internal management resources leverage, thereby enhancing the advantages brought by collaborative resources. This study provides practical insights for local small and medium-sized pharmaceutical companies or other industries, aiding in the formulation of more effective collaboration strategies, and emphasizes the key role of dynamic collaboration capability in corporate competition.